Primary |
Parkinson's Disease |
71.4% |
Restless Legs Syndrome |
5.5% |
Hypertension |
4.4% |
Hyperprolactinaemia |
2.6% |
Glaucoma |
1.8% |
Arthralgia |
1.5% |
Headache |
1.5% |
Insomnia |
1.5% |
Parkinsonism |
1.5% |
Musculoskeletal Stiffness |
1.1% |
Blood Cholesterol Increased |
0.7% |
Dementia Alzheimer's Type |
0.7% |
Depression |
0.7% |
Hypercholesterolaemia |
0.7% |
Muscle Spasms |
0.7% |
Oesophagitis Haemorrhagic |
0.7% |
Polycystic Ovaries |
0.7% |
Prolactinoma |
0.7% |
Prostate Cancer |
0.7% |
Type 1 Diabetes Mellitus |
0.7% |
|
Mitral Valve Incompetence |
17.2% |
Pneumonia |
10.1% |
Cardiac Valve Disease |
8.1% |
Hallucination |
6.1% |
Tremor |
6.1% |
Hypertension |
5.1% |
Aortic Valve Incompetence |
4.0% |
Dyspnoea |
4.0% |
Oedema |
4.0% |
Pathological Gambling |
4.0% |
Pleurisy |
4.0% |
Sexual Dysfunction |
4.0% |
Haemolytic Anaemia |
3.0% |
Interstitial Lung Disease |
3.0% |
Neuroleptic Malignant Syndrome |
3.0% |
Obsessive-compulsive Disorder |
3.0% |
Pneumonia Aspiration |
3.0% |
Posture Abnormal |
3.0% |
Pulmonary Fibrosis |
3.0% |
Aortic Valve Stenosis |
2.0% |
|
Secondary |
Parkinson's Disease |
59.8% |
Hypertension |
4.1% |
Constipation |
3.5% |
Insomnia |
3.5% |
Hyperlipidaemia |
3.2% |
Restless Legs Syndrome |
3.2% |
Drug Use For Unknown Indication |
2.9% |
Bipolar I Disorder |
2.3% |
Dyspepsia |
2.3% |
Ischaemic Cardiomyopathy |
2.3% |
Angina Pectoris |
1.7% |
Gastritis |
1.7% |
Product Used For Unknown Indication |
1.7% |
Glaucoma |
1.5% |
Back Pain |
1.2% |
Microalbuminuria |
1.2% |
Pollakiuria |
1.2% |
Type 2 Diabetes Mellitus |
1.2% |
Drug Effect Decreased |
0.9% |
Arteriosclerosis Obliterans |
0.6% |
|
Pleural Effusion |
11.7% |
Persecutory Delusion |
10.0% |
Respiratory Failure |
8.3% |
Suicide Attempt |
8.3% |
Pneumonia |
6.7% |
Vertigo |
6.7% |
Gait Disturbance |
5.0% |
Psychotic Disorder |
5.0% |
Stereotypy |
5.0% |
Sudden Onset Of Sleep |
5.0% |
Deafness Neurosensory |
3.3% |
Erectile Dysfunction |
3.3% |
Hypoglycaemia |
3.3% |
Neuroleptic Malignant Syndrome |
3.3% |
Rapid Eye Movements Sleep Abnormal |
3.3% |
Sleep Disorder |
3.3% |
Withdrawal Syndrome |
3.3% |
Alanine Aminotransferase Increased |
1.7% |
Aortic Valve Stenosis |
1.7% |
Caesarean Section |
1.7% |
|
Concomitant |
Parkinson's Disease |
47.5% |
Constipation |
4.9% |
Drug Use For Unknown Indication |
4.7% |
Nocardiosis |
3.7% |
Dementia |
3.6% |
Diabetes Mellitus |
3.4% |
Asthenopia |
3.2% |
Hypertension |
3.2% |
Parkinsonism |
3.0% |
Drug Effect Decreased |
2.8% |
Osteoporosis |
2.8% |
Insomnia |
2.4% |
Pancreatic Neuroendocrine Tumour |
2.4% |
Product Used For Unknown Indication |
2.4% |
Anxiety |
2.0% |
Pain |
2.0% |
Osteoarthritis |
1.8% |
Pneumonia |
1.8% |
Back Pain |
1.4% |
Bipolar Disorder |
1.4% |
|
Sudden Onset Of Sleep |
12.4% |
Hallucination |
10.1% |
Chest Discomfort |
9.0% |
Vomiting |
9.0% |
Pyrexia |
5.6% |
Hypercholesterolaemia |
4.5% |
Overdose |
4.5% |
Pneumonia |
4.5% |
Somnolence |
4.5% |
Death |
3.4% |
Erythema |
3.4% |
Hyponatraemia |
3.4% |
Interstitial Lung Disease |
3.4% |
Osteomyelitis |
3.4% |
Stomach Discomfort |
3.4% |
Subdural Haematoma Evacuation |
3.4% |
White Blood Cell Count Decreased |
3.4% |
White Blood Cell Count Increased |
3.4% |
Wound Complication |
3.4% |
Bone Density Decreased |
2.2% |
|
Interacting |
Parkinson's Disease |
50.0% |
Bipolar I Disorder |
33.3% |
Hypercholesterolaemia |
16.7% |
|
|